New carboxysilane-coated iron oxide nanoparticles for nonspecific cell labelling

Contrast Media and Molecular Imaging

Volumn 8, Issue 6, 2013, Pages 466-474

  Bridot, Jean Luc ^a   Stanicki, Dimitri ^a   Laurent, Sophie ^a   Boutry, Sébastien ^b   Gossuin, Yves ^a   Leclère, Philippe ^a   Lazzaroni, Roberto ^a   Vander Elst, Luce ^a   Muller, Robert N ^a,b  

^a UNIVERSITY OF MONS   (Belgium)

^b Center for Microscopy and Molecular Imaging   (Belgium)

Author keywords

Cell labelling; Colloidal stability; Contrast agent; Ferrofluids; Iron oxide; Nanoparticles; Silane

Indexed keywords

CARBOXYLIC ACID; CARBOXYSILANE; IRON OXIDE; NANOPARTICLE; POLYSILOXANE; SILANE DERIVATIVE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL LABELING; CELL TRACKING; CONTROLLED STUDY; INFRARED SPECTROSCOPY; MAGNETOMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

CELL LABELLING; COLLOIDAL STABILITY; CONTRAST AGENT; FERROFLUIDS; IRON OXIDE; NANOPARTICLES; SILANE;

ANIMALS; CELL LINE; COATED MATERIALS, BIOCOMPATIBLE; CONTRAST MEDIA; FERRIC COMPOUNDS; FIBROBLASTS; MAGNETITE NANOPARTICLES; MICE; SILOXANES; STAINING AND LABELING;

EID: 84890938272     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1552     Document Type: Article

References (35)

1. Bruchez M, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science 1998; 281: 2013-2016.
2. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005; 307: 538-544.
3. Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res 2006; 23: 1417-1450.
4. Kim J, Piao Y, Hyeon T. Multifunctional nanostructural materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 2009; 38: 372-390.
5. Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A. Magnetic resonance relaxation properties of superparamagnetic particles. WIREs: Nanomed Nanobiotechnol 2009; 1: 299-310.
6. Laurent S, Boutry S, Mahieu I, Vander Elst L, Muller RN. Iron oxide based MR contrast agents: from chemistry to cell labeling. Curr Med Chem 2009; 16: 4712-4727.
7. Hoehn M, Wiedermann D, Justicia C, Ramos-Cabrer P, Kruttwig K, Farr T, Himmelreich U. Cell tracking using magnetic resonance imaging. J Physiol 2007; 584: 25-30.
8. Kiessling F. Noninvasive cell tracking. Handb Exp Pharmacol 2008: 305-321.
9. Mailänder V, Landfester K. Interaction of nanoparticles with cells. Biomacromolecules 2009; 10: 2379-2400.
10. Petri-Fink A, Hofmann H. Superparamagnetic iron oxide nanoparticles (SPIONs): from synthesis to in vivo studies - a summary of the synthesis, characterization, in vitro, and in vivo investigations of SPIONs with particular focus on surface and colloidal properties. IEEE Trans Nanobiosci 2007; 6: 289-297.
11. Namkung S, Zech CJ, Helmberger T, Reiser MF, Schoenberg SO. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions. J Magn Reson Imag 2007; 25: 755-765.
12. Bulte JW. In vivo MRI cell tracking: clinical studies. Am J Roentgenol 2009; 193: 314-325.
13. Mailänder V, Lorenz MR, Holzapfel V, Musyanovych A, Fuchs K, Wiesneth M, Walther P, Landfester K, Schrezenmeier H. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imag Biol 2008; 10: 138-146.
14. Boutry S, Brunin S, Mahieu I, Laurent S, Vander Elst L, Muller RN. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study. Contrast Media Mol Imag 2008; 3: 223-232.
15. van Buul GM, Farrell E, Kops N, van Tiel ST, Bos PK, Weinans H, Krestin GP, van Osch GJVM, Bernsen MR. Ferumoxides-protamine sulfate is more effective than ferucarbotran for cell labeling: implications for clinically applicable cell tracking using MRI. Contrast Media Mol Imag 2009; 4: 230-236.
16. Monet-Abou K, Montet X, Weissleder R, Josephson L. Transfection agent induced nanoparticle cell loading. J Mol Imag 2005; 4: 165-171.
17. Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark W. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. J Environ Sci Technol 2005; 39: 9370-9376.
18. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003; 24: 1001-1011.
19. Forge D, Roch A, Laurent S, Tellez H, Gossuin Y, Renaux F, Vander Elst L, Muller RN. Optimization of the synthesis of superparamagnetic contrast agents by the design of experiments method. J Phys Chem C 2008; 112: 19178-19185.
20. Thorek DLJ, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006; 34: 23-38.
21. Gupta AK, Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 2005; 26: 1565-1573.
22. Laurent S, Bridot J-L, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles for biomedical applications. Fut Med Chem 2010; 2: 427-449.
23. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physico-chemical characterizations and biological applications. Chem Rev 2008; 108(6): 2064-2110.
24. Nobbmann U, Morfesis A. Light scattering and nanoparticles. Mater Today 2009; 12(5): 52-54.
25. Roch A, Gossuin Y, Muller RN, Gillis P. Superparamagnetic colloid suspensions: water magnetic relaxation and clustering. J Magn Magn Mater 2005; 293: 532-539.
26. Daou TJ, Grenèche JM, Pourroy G, Buathong S, Derory A, Ulhaq-Bouillet C, Donnio B, Guillon D, Begin-Colin S. Coupling agent effect on magnetic properties of functionalized magnetite-based nanoparticles. Chem Mater 2008; 20: 5869-5875.
27. 2 relaxivity for highly sensitive in vivo MRI of tumors. Nano Lett 2012; 12: 3127-3131.
28. 2-weighted spin-echo imaging. ACS Nano 2012; 6: 1619-1624.
29. 2 relaxivity. Nano Lett 2010; 10: 4607-4613.
30. Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imag 1995; 13: 661-674.
31. Lee H, Lee E, Kim DK, Jang NK, Jeong YY, Jon S. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc 2006; 128: 7383-7389.
32. Jain N, Wang Y, Jones SK, Hawkett BS, Warr GG. Optimized steric stabilization of aqueous ferrofluids and magnetic nanoparticles. Langmuir 2010; 26: 4465-4472.
33. Harris LA, Goff JD, Carmichael AY, Riffle JS, Harburn JJ, St. Pierre TG, Saunders M. Magnetite nanoparticle dispersions stabilized with triblock copolymers. Chem Mater 2003; 15(6): 1367-1377.
34. Goodwin J. Colloid and Interfaces with Surfactant and Polymers, an Introduction. Wiley: New York, 2004.
35. Janic B, Rad AM, Jordan EK, Iskander ASM, Ali Md M, Varma NRS, Frank JA, Arbab AS. Optimization and validation of FePro cell labeling method. PLoS One 2009; 4(6): e5873.